Catabasis Pharmaceuticals
Why Robinhood?
You can watch CATB and buy or sell other stocks, ETFs, and their options commission-free!About CATB
Catabasis Pharmaceuticals, Inc. engages in the discovery, development, and commercialization of novel therapeutics. Its lead product candidate is edasalonexent, which is intended for the treatment of Duchenne muscular dystrophy.
CATB Key Statistics
Stock Snapshot
As of today, Catabasis Pharmaceuticals(CATB) shares are valued at $14.47. The company's market cap stands at 1.13B.
On 2026-03-13, Catabasis Pharmaceuticals(CATB) stock opened at —, reached a high of —, and a low of —.
The Catabasis Pharmaceuticals(CATB)'s current trading volume is 0, compared to an average daily volume of 508.7K.
During the past year, Catabasis Pharmaceuticals(CATB) stock moved between $1.20 at its lowest and $8.59 at its peak.
During the past year, Catabasis Pharmaceuticals(CATB) stock moved between $1.20 at its lowest and $8.59 at its peak.
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.